Financial Gravity Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46
Closed -$12.7K 896
2025
Q3
$12.7K Buy
+46
New +$12.6K ﹤0.01% 519
2019
Q4
$155K Sell
132
-116
-47% -$16.7K 0.11% 173
2019
Q3
$33K Sell
248
-115
-32% -$15.1K 0.03% 363
2019
Q2
$44K Sell
363
-126
-26% -$14K 0.04% 342
2019
Q1
$51K Buy
+489
New +$50.5K 0.04% 313
2018
Q3
$0 Hold
2
﹤0.01% 1579
2018
Q2
$0 Hold
2
﹤0.01% 1576
2018
Q1
$0 Buy
+2
New +$189 ﹤0.01% 1486

Other funds holding RMD

Financial Gravity Asset Management's RMD Position: Q4 2025 in Review

Financial Gravity Asset Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 46 shares — an estimated $12.7K sold.

Financial Gravity Asset Management first reported a position in RMD in Q1 2018 and held it in 8 quarters. The position peaked at $155K in Q4 2019. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Financial Gravity Asset Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Financial Gravity Asset Management sold 46 ResMed shares in Q4 2025, an estimated $12.7K.
  • Financial Gravity Asset Management first reported a position in ResMed in Q1 2018 and held it in 8 quarters.
  • Financial Gravity Asset Management's ResMed position peaked at $155K in Q4 2019.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Financial Gravity Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.